Sep 24, 2017 Last Updated 2:27 PM, Sep 22, 2017

New Entry From the Editor :

Rio Tinto commits further $3.15 billion to shareholders in buyback programme

Rio Tinto commits further $3.1…

AusBN - Rio Tinto has announced it will distribute a further AUS$3.15 billi...

BHP surges back to profit thanks to increased prices and improved productivity

BHP surges back to profit than…

AusBN- BHP demonstrated a strong financial performance for the last fiscal ...

Toys R Us to trade as usual in Australia despite filing for bankruptcy

Toys R Us to trade as usual in…

AusBN - Toys R Us has confirmed it will continue to operate as normal in Au...

Healthscope sells Australian pathology operations

AusBN – Crescent Capital Partners has acquired Healthscope’s Australian pathology operations for A$105 million.

Over 500 collection centres and 30 laboratories in Victoria and the Northern Territory will now be operated by Crescent Capital.

Healthscope will also transfer six of its skin clinics to Crescent and the proceeds from the sale will be used to fund its expansion plans at major hospital sites.

Healthscope CEO Robert Cooke said: “Our Australian pathology operations are non-core, have been operating in challenging market conditions for a number of years and their underlying earnings contribution to the group is limited.

 “We remain committed to our international pathology operations, which have consistently performed well over time.” 

@AusBNOnline

This Month's Issue

AusBN Vol3 Iss1

Subscribe

rgn web banner

abn web banner